These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Up-regulation of integrin-linked kinase activity in rat mesangioproliferative glomerulonephritis. Kagami S; Shimizu M; Kondo S; Kitamura A; Urushihara M; Takamatsu M; Yamaji S; Ishigatsubo Y; Kawachi H; Shimizu F Life Sci; 2006 Mar; 78(16):1794-800. PubMed ID: 16309711 [TBL] [Abstract][Full Text] [Related]
5. Contribution of conjugated linoleic acid to the suppression of inducible nitric oxide synthase expression and transcription factor activation in stimulated mouse mesangial cells. Sheu JN; Lin TH; Lii CK; Chen CC; Chen HW; Liu KL Food Chem Toxicol; 2006 Mar; 44(3):409-16. PubMed ID: 16188363 [TBL] [Abstract][Full Text] [Related]
6. Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN. Mahimainathan L; Das F; Venkatesan B; Choudhury GG Diabetes; 2006 Jul; 55(7):2115-25. PubMed ID: 16804083 [TBL] [Abstract][Full Text] [Related]
7. Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis. Adachi H; Fujiwara Y; Kondo T; Nishikawa T; Ogawa R; Matsumura T; Ishii N; Nagai R; Miyata K; Tabata M; Motoshima H; Furukawa N; Tsuruzoe K; Kawashima J; Takeya M; Yamashita S; Koh GY; Nagy A; Suda T; Oike Y; Araki E Biochem Biophys Res Commun; 2009 Feb; 379(4):806-11. PubMed ID: 19094966 [TBL] [Abstract][Full Text] [Related]
8. Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase. Gustafsson M; Levin M; Skålén K; Perman J; Fridén V; Jirholt P; Olofsson SO; Fazio S; Linton MF; Semenkovich CF; Olivecrona G; Borén J Circ Res; 2007 Oct; 101(8):777-83. PubMed ID: 17761930 [TBL] [Abstract][Full Text] [Related]
9. Effects of chemically modified tetracyclines on iNOS in mesangial cells: impact on experimental glomerulonephritis. Trachtman H Adv Dent Res; 1998 Nov; 12(2):123-5. PubMed ID: 9972135 [No Abstract] [Full Text] [Related]
10. Effects of CpG-ODN on gene expression in formation of foam cells. Li K; Wan B; Hu ZL; He Y; He XW; Jiang L; Sun SH Acta Pharmacol Sin; 2005 Nov; 26(11):1359-64. PubMed ID: 16225759 [TBL] [Abstract][Full Text] [Related]
11. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice. Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255 [TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor (PAF) increase intracellular lipid accumulation by increasing both LDL and scavenger receptors in human mesangial cells. Fragopoulou E; Iatrou C; Antonopoulou S; Ruan XZ; Fernando RL; Powis SH; Moorhead JF; Varghese Z J Lab Clin Med; 2006 Jun; 147(6):281-9. PubMed ID: 16750665 [TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. Eremina V; Cui S; Gerber H; Ferrara N; Haigh J; Nagy A; Ema M; Rossant J; Jothy S; Miner JH; Quaggin SE J Am Soc Nephrol; 2006 Mar; 17(3):724-35. PubMed ID: 16436493 [TBL] [Abstract][Full Text] [Related]
15. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis. Moerland M; Samyn H; van Gent T; van Haperen R; Dallinga-Thie G; Grosveld F; van Tol A; de Crom R Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1277-82. PubMed ID: 18421000 [TBL] [Abstract][Full Text] [Related]
16. Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice. Mutoh M; Niho N; Wakabayashi K Biol Chem; 2006 Apr; 387(4):381-5. PubMed ID: 16606335 [TBL] [Abstract][Full Text] [Related]
17. In vivo arterial lipoprotein lipase expression augments inflammatory responses and impairs vascular dilatation. Takahashi M; Hiyama Y; Yokoyama M; Yu S; Hu Y; Melford K; Bensadoun A; Goldberg IJ Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):455-62. PubMed ID: 18258818 [TBL] [Abstract][Full Text] [Related]
18. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice. Krohn R; Raffetseder U; Bot I; Zernecke A; Shagdarsuren E; Liehn EA; van Santbrink PJ; Nelson PJ; Biessen EA; Mertens PR; Weber C Circulation; 2007 Oct; 116(16):1812-20. PubMed ID: 17893273 [TBL] [Abstract][Full Text] [Related]
19. Lipoprotein lipase and atherosclerosis. Kobayashi J; Mabuchi H Ann Clin Biochem; 2015 Nov; 52(Pt 6):632-7. PubMed ID: 25995285 [TBL] [Abstract][Full Text] [Related]
20. Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development. Agrawal S; Febbraio M; Podrez E; Cathcart MK; Stark GR; Chisolm GM Circulation; 2007 Jun; 115(23):2939-47. PubMed ID: 17533179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]